Thyroid-on-a-chip: An Organoid Platform For In Vitro Assessment of Endocrine Disruption

ThyroidOrganoids
Written by Aleks

Carvalho, D. J., Kip, A. M., Romitti, M., Nazzari, M., Tegel, A., Stich, M., Krause, C., Caiment, F., Costagliola, S., Moroni, L., Giselbrecht, S., Adv. Healthcare Mater. 2022, 2201555. https://doi.org/10.1002/adhm.202201555

Aleks
Previous

Emerging Technologies in Thyroid Biology: Pushing the Frontiers of Thyroid Research
Next

Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis